Skip to content
Disclosery

Signpost Capital Advisors, LP

Follow

13F filer, CIK 1560812, New York, NY

Signpost Capital Advisors, LP reported $34,236,000 across 7 holdings for the quarter ended 2017-03-31, in a 13F-HR filed 2017-05-01.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001560812-17-000006

Changes against Q4 2016 are not shown: its report omitted holdings under a confidential treatment request (9 positions on file), so every position would read as new.

Period
2017-03-31
Reported value
$34.2M
Holdings
7
Top 10 weight
100%
New
Sold out

Holdings, Q1 2017

Share positions as resolved from 13F-HR 0001560812-17-000006, largest first. % of portfolio is the value over $34,236,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TRIPTRIPADVISOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: not reported; 2016Q4: 183,300 shares; 2017Q1: 241,229 shares 241,229$10.4M30.41%Timeline
CALPINE CORPCALPINE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q2: not reported; 2015Q3: 1,111,059 shares; 2015Q4: 1,281,825 shares; 2016Q1: 1,612,201 shares; 2016Q2: 1,698,090 shares; 2016Q3: 1,962,463 shares; 2016Q4: 1,541,173 shares; 2017Q1: 942,103 shares 942,103$10.4M30.41%
SRGSERITAGE GROWTH PPTYSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 83,770 shares; 2016Q1: 180,427 shares; 2016Q2: 180,427 shares; 2016Q3: 173,072 shares; 2016Q4: 167,500 shares; 2017Q1: 116,281 shares 116,281$5.02M14.65%Timeline
DVADAVITA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: 88,900 shares; 2016Q4: 114,776 shares; 2017Q1: 63,506 shares 63,506$4.32M12.61%Timeline
MEDICINES COMEDICINES COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q2: 254,591 shares; 2015Q3: 176,192 shares; 2015Q4: 176,192 shares; 2016Q1: 270,206 shares; 2016Q2: 219,998 shares; 2016Q3: 151,356 shares; 2016Q4: 110,883 shares; 2017Q1: 34,423 shares 34,423$1.68M4.92%
RETROPHIN INCRETROPHIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: not reported; 2016Q2: not reported; 2016Q3: 203,141 shares; 2016Q4: 163,741 shares; 2017Q1: 84,111 shares 84,111$1.55M4.54%
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 34,365 shares; 2016Q2: 34,365 shares; 2016Q3: 34,365 shares; 2016Q4: 33,065 shares; 2017Q1: 16,485 shares 16,485$845K2.47%Timeline

How Q1 2017 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001560812-17-000006 base2017-05-01acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001560812-17-000006 Quarter ended 2017-03-312017-05-01acceptance time not in the bulk data set
13F-HR 0001560812-17-000001 Quarter ended 2016-12-312017-02-13acceptance time not in the bulk data set
13F-HR 0001560812-16-000024 Quarter ended 2016-09-302016-11-10acceptance time not in the bulk data set
13F-HR 0001560812-16-000020 Quarter ended 2016-06-302016-08-12acceptance time not in the bulk data set
13F-HR/A 0001560812-16-000019 Quarter ended 2016-03-312016-07-13acceptance time not in the bulk data set
13F-HR 0001560812-16-000017 Quarter ended 2016-03-312016-05-13acceptance time not in the bulk data set
13F-HR 0001560812-16-000015 Quarter ended 2015-12-312016-02-12acceptance time not in the bulk data set
13F-HR/A 0001560812-15-000012 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0001560812-15-000010 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR 0001560812-15-000008 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001560812-15-000006 Quarter ended 2015-03-312015-05-14acceptance time not in the bulk data set
13F-HR 0001560812-15-000004 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR 0001560812-14-000015 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR/A 0001560812-14-000014 Quarter ended 2014-06-302014-08-21acceptance time not in the bulk data set
13F-HR 0001560812-14-000013 Quarter ended 2014-06-302014-08-13acceptance time not in the bulk data set
13F-HR 0001560812-14-000008 Quarter ended 2014-03-312014-05-14acceptance time not in the bulk data set
13F-HR/A 0001560812-14-000006 Quarter ended 2013-12-312014-02-12acceptance time not in the bulk data set
13F-HR 0001560812-14-000003 Quarter ended 2013-12-312014-02-11acceptance time not in the bulk data set
13F-HR 0000919574-13-006325 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0000919574-13-004558 Quarter ended 2013-06-302013-08-12acceptance time not in the bulk data set